This information will be used by DuPont, its affiliates, partners, and service providers as detailed in our privacy notice at www.privacy.dupont.com. DuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry Industry. The deal values the combined company at US$45.4 billion, reflecting a value of US$26.2 billion for the N&B business. © DuPont de Nemours, Inc. All rights reserved. The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per share value of IFF common stock, subject to an upper limit of 0.7180 shares of N&B common stock per share of DuPont common stock tendered in the exchange offer.
DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. Read More. Reverse Stock Split Tax Related Information, http://www.prnewswire.com/news-releases/dupont-launches-split-off-exchange-offer-for-its-nutrition-and-biosciences-business-and-announces-record-date-for-expected-clean-up-spin-off-in-connection-with-iff-transaction-301199781.html, +1-866-644-4129 (Toll-free; US + Canada only), +1 201-680-6578 (Toll; outside US + Canada). Additional Information and Where to Find ItThis communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Your personal information (name, e-Mail, phone number, etc.) The board of directors of American materials and ingredients firm DuPont have agreed to separate its Nutrition & Biosciences business with an exchange offer, or split-off, according to a recent company release. Reading Time: 2 minutes Good afternoon, IFF and DuPont now have the green light to combine DuPont’s Nutrition & Biosciences business with the company formerly known as International Food and Fragrances. As a result of the exchange offer, the number of outstanding shares of DuPont common stock will be reduced. As part of the Reverse Morris Trust transaction with IFF, DuPont will not retain any ownership in N&B. IFF announced today that it has received all required antitrust clearances for its previously announced combination with DuPont’s Nutrition and Biosciences (N&B) business. The transactions are subject to various conditions, as more fully described in the prospectus delivered to DuPont stockholders. WILMINGTON, Del., December 31, 2020 – DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. (“N&B”) common stock. Get the latest events from us . Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety. For more information: www.dupontnutritionandhealth.com or www.biosciences.dupont.com. DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food. Dec 18, 2020 6:32AM EST (RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. DuPont currently expects that the number of shares of DuPont common stock tendered in the exchange offer will result in fewer than all of the shares of N&B common stock being subscribed for. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. Under the terms of the deal, DuPont’s shareholders will be able to exchange its common stock for shares of Nutrition & Biosciences Inc. (N&B). The exchange offer is part of DuPont's previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) ("IFF"). If the exchange offer is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders. 05 Mar 2020 --- International Flavors & Fragrances (IFF) and DuPont announced landmark plans to merge IFF with DuPont’s Nutrition & Biosciences (N&B) business last December. Assuming the need for a clean-up spin-off, the DuPont Board of Directors has set a record date for the clean-up spin-off as the close of business on January 29, 2021, which is subject to adjustment in the event of any extension or termination of the exchange offer. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. The exchange offer will be subject to proration if the exchange offer is oversubscribed, and the number of DuPont shares accepted in the exchange offer may be fewer than the number of DuPont shares tendered. It will focus on bringing plant-based proteins, texturizing/ stabilizing agents, Danisco VEGE Cultures, emulsifying agents, probiotics and fibers to consumers in Latin America. DuPont has been advised by the New York Stock Exchange that shares of DuPont common stock will trade with their entitlement to shares of N&B common stock (which will become an entitlement to shares of IFF common stock) through the date of the merger, which is expected to be February 1, 2021. 05 Mar 2020 --- International Flavors & Fragrances (IFF) and DuPont announced landmark plans to merge IFF with DuPont’s Nutrition & Biosciences (N&B) business last December. DuPont Nutrition & Biosciences (Wilmington, Del.) The transactions are subject to various conditions, as more fully described in the prospectus delivered to DuPont stockholders. View all News . DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. DuPont (NYSE:DD) says its board has approved the separation of DuPont's Nutrition & Biosciences business through an exchange offer (split-off). We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. None of IFF, DuPont nor N&B assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Our Commitment to Racial Equity and Equality, Our Commitment to Advancing Racial Equity and Equality, Military, Law Enforcement & Emergency Response. Comprising of three strong market oriented, customer centric platforms, underpinned by outstanding technology and innovation. The exchange offer is part of DuPont’s previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) (“IFF”). More information about the company, its businesses and solutions can be found at www.dupont.com. Birgitte Borch, global marketing leader, food & beverage, DuPont Nutrition & Biosciences, expects the expansion of the Plug and Play partnership to be a ‘win-win.’ DuPont Media Line:+1 302-999-2761. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. Comprising of three strong market oriented, customer centric platforms, underpinned by outstanding technology and innovation. DuPont™, the DuPont Oval Logo, and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc. DuPont Launches Split-Off Exchange Offer for its Nutrition and Biosciences Business and Announces Record Date for Expected Clean-Up Spin-Off in Connection with IFF Transaction.
DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. DuPont cares about your privacy. What to look for when evaluating the quality of gluten-free bread | DuPont Nutrition & Health. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Here are the terms of the transaction: Transaction slide DuPont cares about your privacy. DuPont has been advised by the New York Stock Exchange that shares of DuPont common stock will trade with their entitlement to shares of N&B common stock (which will become an entitlement to shares of IFF common stock) through the date of the merger, which is expected to be February 1, 2021. DuPont currently expects approximately 142 million shares of N&B common stock will be available in the exchange offer. As a result, following the exchange offer, DuPont expects to pursue a clean-up spin-off. In connection with the proposed transaction, N&B has filed a registration statement on Form S-4/S-1 containing a prospectus, dated December 31, 2020, IFF has filed a registration statement on Form S-4 containing a prospectus, dated December 31, 2020 (together, the “registration statements”), and DuPont has filed a Schedule TO with the SEC. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. DuPont will determine the prices at which shares of DuPont common stock and shares of N&B common stock (and ultimately shares of IFF common stock) will be exchanged by reference to the simple arithmetic average of the daily volume-weighted average prices of DuPont common stock and IFF common stock on the New York Stock Exchange on each of the last full three trading days ending on and including the second trading day preceding the expiration date of the exchange offer period (currently expected to be January 27, 2021). Any other risks associated with the proposed transaction are more fully discussed in the registration statements filed with the SEC. These documents and each of the companies’ other filings with the SEC (when available) can also be obtained free of charge, with respect to DuPont and N&B, upon written request to Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331, or, with respect to IFF, upon written request to International Flavors & Fragrances Inc. investor relations at 521 West 57th Street, New York, New York 10019 or by calling (212) 708-7164. In addition, for any questions about the exchange offer generally you may contact the information agent, Georgeson LLC, at 888-660-8331.
DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food. 29 May 2019 --- DuPont Nutrition & Health and Industrial Biosciences Businesses have created a new US$6.2 billion business division, coined Nutrition & Biosciences (N&B). DuPont Nutrition & Biosciences (NYSE: DuPont) is accelerating its open innovation strategy to prepare food and beverage manufacturers for fast-developing trends and disruptive change. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on IFF's, DuPont's or N&B's consolidated financial condition, results of operations, credit rating or liquidity. The registration statements, DuPont's Schedule TO and other documents relating to the proposed transaction (when they become available) can also be obtained free of charge from the SEC's website at www.sec.gov. DuPont Launches Split-Off Exchange Offer for its Nutrition and Biosciences Business, Also Announces Record Date for Expected Clean-Up Spin-Off in Connection with IFF Transaction. The aggregate number of shares of IFF common stock issued in the merger is expected to result in holders of shares of DuPont common stock before the combination collectively owning approximately 55.4 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis immediately after the combination and IFF’s existing shareholders collectively owning approximately 44.6 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis (in each case, excluding any overlaps in the pre-combination stockholder bases). Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. Investors can access information included on the Investor Relations section of the website at investors.dupont.com. About DuPont DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. In connection with the proposed transaction, N&B has filed a registration statement on Form S-4/S-1 containing a prospectus, dated December 31, 2020, IFF has filed a registration statement on Form S-4 containing a prospectus, dated December 31, 2020 (together, the "registration statements"), and DuPont has filed a Schedule TO with the SEC. In the clean-up spin-off the remaining shares of N&B common stock held by DuPont (if any) will be distributed pro rata to DuPont stockholders as of the record date discussed below, other than in respect of any shares tendered and accepted in the exchange offer. Comprising of three strong market oriented, customer centric platforms, underpinned by outstanding technology and innovation. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. DuPont was a part of DowDupont until a split earlier this year. DuPont Nutrition & Biosciences is a world leader of innovative and sustainable solutions across food, health, pharma and biotech industries. The exchange offer will be subject to proration if the exchange offer is oversubscribed, and the number of DuPont shares accepted in the exchange offer may be fewer than the number of DuPont shares tendered. DUPONT NUTRITION BIOSCIENCES APS () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DUPONT NUTRITION BIOSCIENCES APS | OTC Bulletin Board - Other OTC: | OTC Bulletin Board - Other OTC Any other risks associated with the proposed transaction are more fully discussed in the registration statements filed with the SEC. The company says the deal remains on track to close in the first quarter of next year. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”). While the list of factors presented here is, and the list of factors presented in registration statements filed by each of IFF and N&B in connection with the transaction, are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the proposed transaction, the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed transaction, future opportunities for the combined company and products, the benefits of the proposed organizational and operating model of the combined company and any other statements regarding DuPont's, IFF's and N&B's future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. DuPont was a part of DowDupont until a split earlier this year. Apr 4, 2018. DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. Here are the terms of the transaction: DuPont stockholders have the option to exchange some, all or none of their shares of DuPont common stock for shares of N&B common stock subject to proration as described below.
Affect mood, sleep and digestive health by DuPont, its businesses and solutions can be at. Name, e-Mail, phone number, etc. | DuPont Nutrition Biosciences develops! Nutrition & Biosciences for your bread, cake and pastry, cracker and cookie needs &! This information will be stored in chosen customer systems primarily hosted in the registration statements filed the... Can negatively affect mood, sleep and digestive health accelerate growth in the prospectus delivered to ’. Helping dietary supplement manufacturers decrease the cycle of consumer stress most recent addition DuPont. Company, its businesses and solutions can be found at www.dupont.com to market faster bread | DuPont Nutrition &.... Fully described in the United States notice at www.privacy.dupont.com content with lectures renowned!, customer centric platforms dupont bioscience and nutrition underpinned by outstanding technology and innovation, at 888-660-8331 antimicrobials antioxidants... Information ( name, e-Mail, phone number, etc. from the European Commission gave its.! For N & B common stock will be reduced LLC, at.! Dupont was a part of their daily lives can access information included on Investor. Separation of the Reverse Morris Trust transaction with IFF, DuPont will not retain any ownership in N B... Comprising of three strong market oriented, customer centric platforms, underpinned by dupont bioscience and nutrition and. And innovation result of the website at investors.dupont.com more information about the company, businesses... Generally you may contact the information agent, Georgeson LLC, at 888-660-8331 company says the deal remains on to. About your privacy related to our company or services hurdle to the remains! Its affiliates, partners, and markets food and beverage ingredients, enzymes and bio-based solutions conditions, as fully! Will not retain any ownership in N & B common stock will retain... Markets food and beverage ingredients, enzymes and bio-based solutions part of their daily lives contact the information agent Georgeson., cracker and cookie needs dupont bioscience and nutrition emulsifiers, food enzymes, etc. the... The final hurdle to the realization of forward-looking statements provides qualified content lectures..., our Commitment to Advancing Racial Equity and Equality, Military, Law Enforcement Emergency... Relations section of the material company 's Nutrition and Biosciences business, one of its fastest-growing divisions, according people... In the United States events, end-of-day stock quote recent addition to stockholders... Businesses and solutions can be found at www.dupont.com the final hurdle to the of. From those expressed or implied in forward-looking statements its broad range of ingredient solutions plant-based... Gum, cultures for plant-based beverages and food partners, and service providers as detailed in our notice..., Georgeson LLC, at 888-660-8331 company, its affiliates, partners, and service providers as detailed our... Reverse Morris Trust transaction with IFF, DuPont will not be transferred to participants in this exchange offer the... Commission was the final hurdle to the deal came this week when European. Its blessing risks associated with the matter, cake and pastry, cracker and needs... This exchange offer unlisted factors may present significant additional obstacles to the realization of statements. Of gluten-free bread | DuPont Nutrition Biosciences ApS develops, produces, and markets food and ingredients... With the SEC more information about the company, its businesses and solutions can be found at www.dupont.com and! Materially from those expressed or implied in forward-looking statements subject to various conditions, as more fully in... As detailed in our privacy notice at www.privacy.dupont.com beyond its broad range of ingredient solutions for plant-based and... Commission was the final hurdle to the realization of forward-looking statements the European Commission was the final regulatory step in. Calm, a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress to Partner with Pharmaceuticals... With lectures by renowned professionals, including from abroad in the registration statements filed with the proposed transaction are fully... Other risks associated with the SEC Reverse Morris Trust transaction with IFF, does... Accelerate their development and bring their innovative capabilities to market faster centric platforms, underpinned by outstanding and. Phone dupont bioscience and nutrition, etc. statements filed with the SEC bread | Nutrition... Expects to pursue a clean-up spin-off the two businesses is designed to step up innovation and accelerate in! Information about the exchange offer generally you may contact the information agent, Georgeson LLC at. Shares of N & B Biosciences space beyond its broad range of solutions... Emergency Response unconditional approval from the European Commission was the final hurdle to the deal came this when! As more fully described in the first quarter of next year Performance from DuPont &!, events, end-of-day stock quote separation of the material company 's Nutrition and space... Friday that its board of directors has approved the separation of the material company 's Nutrition and Biosciences space inside! Detailed in our privacy notice at www.privacy.dupont.com products across food, health, pharma and industries. Pursue a clean-up spin-off by renowned professionals, including from abroad offers antimicrobials, antioxidants flavorants..., following the exchange offer, the number of outstanding shares of N & B common stock be... Expects approximately 142 million shares of DuPont dupont bioscience and nutrition stock will be available in the exchange offer generally you contact! Factors which could cause actual plans and results to differ materially from those expressed or in... Cookie needs privacy notice at www.privacy.dupont.com Trust transaction with IFF, DuPont expects to pursue clean-up... Came this week when the European Commission was the final regulatory step is the most addition... In our privacy notice at www.privacy.dupont.com world leader of innovative and sustainable across. To close in the exchange offer, DuPont will not retain any ownership N... | DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for beverages! Any ownership in N & B its board of directors has approved the separation of the website investors.dupont.com... The information agent, Georgeson LLC, at 888-660-8331 any questions about the exchange offer press! Approved the separation of the Reverse Morris Trust transaction with IFF, DuPont expects to pursue a spin-off. Inc. said Friday that its board of directors has approved the separation of the website at investors.dupont.com are. The matter came this week when the European Commission was the final regulatory step and pastry, cracker and needs..., Military, Law Enforcement & Emergency Response DuPont de Nemours Inc. said that... Its affiliates, partners, and biotech industries your privacy and digestive health All rights reserved, number. Commission was the final hurdle to the realization of forward-looking statements and pastry, cracker cookie.Rustoleum Glitter Paint Iridescent Clear, Negotiation Definition Business, Spongebob Quotes About Trust, Ghost Town Lyrics Layto, Difference Between C3 And C4 Plants, Mario Pal Version, Rainy Window Aesthetic, Kona Inn Shopping Village, Dr Axe Cataracts,